Effect of somatostatin and octreotide acetate on OP-CCK-stimulated exocrine secretion in the denervated canine pancreas

Pancreas

Volumn 13, Issue 3, 1996, Pages 304-310

  Garvin, Paul J ^a,b   Burton, Frank R ^a   Reese, Jeffrey C ^a   Dysarz III, Francis A ^a   Lingle, David ^a   Niehoff, Michael L ^a   Pandya, Prashant K ^a   Presti, Michael E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Exocrine secretion; Pancreas transplant; Somatostatin

Indexed keywords

AMYLASE; BICARBONATE; CHOLECYSTOKININ OCTAPEPTIDE; OCTREOTIDE; SOMATOSTATIN;

AMYLASE RELEASE; ANIMAL TISSUE; ARTICLE; AUTOGRAFT; CONTROLLED STUDY; DENERVATION; DOG; FEMALE; NONHUMAN; PANCREAS ACINUS; PANCREAS SECRETION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL;

EID: 0029838655     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199610000-00014     Document Type: Article

References (30)

1. Williams ST, Woltering EA, O'Dorisio TM, Fletcher WS. Effect of octreotide acetate on pancreatic exocrine function. Am J Surg 1989;157:459-62.
2. Garvin PJ, Burton FR, Reese JC, Lingle D, Pandya PK, Niehoff ML. The effect of octreotide acetate on meal-stimulated exocrine secretion in canine pancreatic autografts. Transplantation 1991;52:453-7.
3. Schlegel W, Harvey RF, Raptis S, Oliver JM, Pfeiffer EG. Inhibition of cholecystokinin-pancreozymin release by somatostatin. Lancet 1977;12:166-8.
4. Boden G, Sivitz MC, Owen OE, Essa-Koumar N, Landor JH. Somatostatin suppresses secretin and pancreatic exocrine secretion. Science 1975;190:163-5.
5. Misumi A, Shiratori K, Lee KY, Barkin JS, Chey WY. Effects of SMS 201-995, a somatostatin analogue, on the exocrine pancreatic secretion and gut hormone release in dogs. Surgery 1988;103:450-5.
6. Myren CJ, Wara P, Christensen JB. Somatostatin in the treatment of persisting pancreatic fistula. A report of two cases. Ann Chir Gynaecol 1986;75:295-7.
7. Prinz RA, Pickleman J, Hoffman JP. Treatment of pancreatic cutaneous fistulas with a somatostatin analog. Am J Surg 1988;155:36-42.
8. Cooper MM, Wright FH, Smith JL, Corry RJ. Successful treatment of a high-output fistula with a somatostatin analog following pancreas transplantation. Transplant Proc 1989; 21:3738-41.
9. Rosenberg L, Dafoe DC, Schwartz R, et al. Administration of somatostatin analog (SMS 201-995) in the treatment of a fistula occurring after pancreas transplantation. Transplantation 1987;43:764-6.
10. DiCostanzo J, Cano N, Richieri JP, Mercier R, Lafille C, Lepeuch D. Treatment of external gastrointestinal fistulas by a combination of total parenteral nutrition and somatostatin. J Parent Enterai Nutr 1987;11:465-70.
11. Tamura K, Sutherland DER, Kaneko G. Exocrine function of the heterotopic transplanted pancreas segment: influence of denervation in dogs. Pancreas 1988;3:324-31.
12. Matsushita K, Okabayashi Y, Hasegawa H, et al. In vitro inhibitory effect of somatostatin on secretin action in exocrine pancreas of rats. Gastroenterology 1993;104:1146-52.
13. Garvin PJ, Niehoff ML, Burton F. The effect of terbutaline on exocrine function in the denervated canine pancreas. Transplantation 1988;46:739-43.
14. Groth CG. Clinical pancreatic transplantation. Transplant Proc 1985;17:302-6.
15. Munda R, Tom WW, First MR, Gartside P, Alexander JW. Pancreatic allograft exocrine urinary tract diversion. Transplantation 1987;43:95-9.
16. Nghiem DD, Gonwa TA, Corry RJ. Metabolic effects of urinary diversion of exocrine secretions in pancreatic transplantation. Transplantation 1987;43:70-3.
17. Reichlin S. Somatostatin. N Engl J Med 1983;309:1495,556.
18. Arnold R, Lankisch PG. Somatostatin and the gastrointestinal tract. Clin Gastroenterol 1989;9:733.
19. Esteve JP, Susini C, Vaysse N, et al. Binding of somatostatin to pancreatic acinar cells. Am J Physiol 1984;247:G62-9.
20. Sakamoto C, Goldfine ID, Williams JA. The somatostatin receptor on isolated pancreatic acinar cell plasma membrane. J Biol Chem 1984;259:9623-7.
21. Mueller MK, Kessel B, Hutt T, Kath R, Layer P, Goebell H. Effects of somatostatin-14 on gastric and pancreatic responses to hormonal and neural stimulation using an isolated perfused rat stomach and pancreas preparation. Pancreas 1988;3:303-10.
22. Singh M. Effect of somatostatin on amylase secretion from in vivo and in vitro rat pancreas. Dig Dis Sci 1986;31:506-12.
23. Annibale B, Delle Fave G, Barbetti F, et al. Dose-response effect of somatostatin-14 on human basal pancreatic hormones. Pancreas 1987;2:551-6.
24. Henderson JR, Daniel PM, Fraser PA. The pancreas as a single organ: the influence of the endocrine upon the exocrine part of the gland. Gut 1981;22:158-67.
25. Williams JA, Goldfine I. The insulin-acinar relationship. In: Go VLW, Gardner JD, et al., eds. The exocrine pancreas. New York: Raven Press, 1986:347-60.
26. Williams JA, Goldfine ID. The insulin-pancreatic acinar axis. Diabetes 1985;34:980-6.
27. Garry DJ, Garry MG, Williams JA, Mahoney WC, Sorenson RL. Effect of islet hormones on amylase secretion and localization of somatostatin binding sites. Am J Physiol 1989;256:G897-904.
28. Muller MK, Schonfeld JV, Singer MV. Role of somatostatin in regulation of insular acinar axis. Dig Dis Sci 1993;35:1537-42.
29. Lifson N, Kramlinger K, Mayrand R, Lender J. Blood flow in the rabbit pancreas with special reference to islets of Langerhans. Gastroenterology 1980;79:466-73.
30. Konturek SJ, Tasler J, Obtulowiez W, Coy DH, Schally AV. Effect of growth hormone-releasing inhibiting hormone on hormones stimulating exocrine pancreatic secretion. J Clin Invest 1976;58:1-6.